BioSpace News Archive

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance, today announced that it has received comments from the U.S. Food and Drug Administration (FDA) on the full clinical hold of its Inv

Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “The Company”), a leading biosciences and diagnostics company, announced today that the company estimates revenue to meet or exceed $27 million, representing sequential growth of at least 40%, for the quarter ended October 31, 2020. Enzo Biochem, Inc. also announced today that Fabian Blank and Peter Clemens have resigned from the company board of directors, effective immediately. Both board members were

Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the third quarter and nine months ending September 30, 2020. Leonard Osser, Interim Chief Executive Officer of Milestone Scientific, commented, “This quarter, our dental business improved considerably as dental offices began to

Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces the re-launch of its corporate website, www.nemauramedical.com, and the website for its flagship program, BEAT™diabetes,

Dr. Rakesh Jetly Appointed Chief Medical Officer Company Announces International Expansion of Clinical Trial Sites for Phase 2A Study into Psychedelic Treatments for PTSD in Veterans

Axion BioSystems has launched the Maestro ZHT high-throughput screening platform, leveraging their expertise in live-cell instrumentation to add a new dimension to drug discovery and development.

The temperature of the human body can be measured in numerous ways. Earlier, body temperature was measured using contact thermometers that were placed on the forehead or in the mouth, ear, armpit, or rectum (in case of children).

The increasing demand from the electronics sector stands as the major factor boosting the global remote plasma source market.

Ultrasound technologies have been used prolifically in ophthalmology for treating wide range of pathologies, particularly glaucoma, retinal disorders, and tumors.

Colorectal cancer starts within the colon or the rectum. These cancers can also be called colorectal carcinoma, colon cancer, or rectal cancer, reckoning on where they begin. Colorectal carcinoma and rectal cancer are often grouped because they need several features in common.